Phase II clinical trial of peptide vaccination with HLA-A2402-restricted KIF20A and VEGFR1 epitope peptides with gemcitabine chemotherapy in patients with unresectable advanced pancreatic cancer

Update Il y a 4 ans
Reference:

  • | Country :
  • Japan
  • | organs :
  • -
  • | Specialty :
  • -

Extract


Inclusion criteria

  • Pancreatic cancer

Links